Wael A. Harb
bod
General Science
Akanocure Pharmaceuticals
United States of America
Biography
Wael A. Harb, M.D. : Dr. Harb developed his specialization in both Internal Medicine and Medical Oncology at the Indiana University School of Medicine. He is the founder of Horizon Oncology Center and the founder, President and CEO of Horizon Bioadvance. Previously, he served as Division Director of Cancer Services and Research at IU Health Arnett. He is committed to clinical research, working directly with IU Health Arnett’s system partner and IU Simon Cancer Center to research new therapeutics to treat cancer when there is no standard treatment available. He is currently the Principal Investigator for over 25 active clinical protocols ranging from Phase I to Phase III studies. As Division Director for Research, he was responsible for the oversight of over 90 active research trials within the IU Health Arnett system. He currently holds faculty positions at both Indiana University and Purdue University. He serves as Chairman of Community Cancer Network; a nonprofit organization that helps cancer patients; and as the coordinator for the Lafayette Medical Education Foundation. He is also a Board Member and Chief Community Officer of the Hoosier Oncology Group.
Research Interest
Medical